E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/8/2006 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

S&P boosts Baxter

Standard & Poor's said it raised its ratings on Baxter International Inc. and removed them from CreditWatch, where they were placed with positive implications on Aug. 2.

The long-term corporate credit rating was raised to A from A- and the outlook is positive, S&P said, noting that the short-term rating was raised to A-1 from A-2.

This rating action reflects the company's broad product and geographic diversity and management's demonstrated ability over the past two years to significantly improve operating and financial performance, the agency noted.

The A rating reflects Baxter's strength as a leading manufacturer of diversified and relatively noncyclical medical products, the agency said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.